Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes

NCT03235973 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute
Leukemia, Lymphoblastic, Acute

Interventions

DRUG: Fludarabine-Cladribine-Busulfan conditioning regimen

Sponsor

Institut Paoli-Calmettes